SCHEMBL17810908

SCHEMBL17810908

O=C(O)c1ccc(N=Cc2ccc(O)cc2C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.60
EGFR P00533 3/20 0.57
LCK P06239 1/20 0.57
CA1 P00915 7/20 0.56
TSHR P16473 1/20 0.46
KDM4E B2RXH2 1/20 0.45
PKM P14618 1/20 0.45
CA12 O43570 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
CA3 P07451 1/20 0.44
TYR P14679 1/20 0.44
DRD1 P21728 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17826399 1.00 CA2 (0.60) CA2EGFRLCKCA1TSHR
SCHEMBL17810907 1.00 CA2 (0.60) CA2EGFRLCKCA1TSHR
SCHEMBL7821870 0.86 CA2 (0.62) CA2EGFRLCKCA1TSHR
SCHEMBL7821874 0.86 CA2 (0.62) CA2EGFRLCKCA1TSHR
SCHEMBL20334064 0.83 EGFR (0.71) CA2EGFRLCKCA1TSHR
SCHEMBL9404117 0.83 EGFR (0.71) CA2EGFRLCKCA1TSHR
SCHEMBL11415394 0.82 CA2 (0.60) CA2EGFRLCKCA1TSHR
SCHEMBL11415397 0.82 CA2 (0.60) CA2EGFRLCKCA1TSHR
SCHEMBL11408882 0.81 CA2 (0.54) CA2EGFRLCKCA1TSHR
SCHEMBL11408885 0.81 CA2 (0.54) CA2EGFRLCKCA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365532-B1 Synthesis, composition and use of novel therapeutic and cosmetic Schiff base products formed by reaction of a carbonyl containing moeity with a transimination nucleophilic catalyst and the use of transimination nucleophilic catalysts to increase the rate at which carbonyl containing therapeutic and cosmetic actives form Schiff base products with biological amines Nanometics, LLC. (US) 2016-06-14 US disclosed